SEAMLESS Trademark
Trademark Overview
On Thursday, December 14, 2023, a trademark application was filed for SEAMLESS with the United States Patent and Trademark Office. The USPTO has given the SEAMLESS trademark a serial number of 79408326. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, May 21, 2025. This trademark is owned by Seamless Therapeutics GmbH. The SEAMLESS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical and biological preparations and, gene therapies and gene-editing therapies, all for the treatment of genetic and viral diseases; medical, pharmaceutical and biopharmaceutical preparations and programmable recombinases substances for the treatment of genetic and viral diseases; pharmaceutical goods and preparations, namely, gene transfer, regulation, modulation and delivery medications for the treatment of genetic and viral diseases and disorders; products, agents, for medical purposes, for veterinary purposes in the nature of gene and gene editing therapies; genome editable enzymes being enzymes for medical purposes; DNA recombinant enzymes being enzymes for medical purposes; DNA editable enzymes, especially, recombinases and integrases being enzymes for medical purposes; genome editable enzymes for the treatment of diseases being enzymes for medical purposes; DNA recombinant enzymes for the treatment of diseases being enzymes for medical purposes; DNA editable enzymes, ...
Chemicals for use in industry and science; biological preparations for use in industry and science, biological reagents, for use in industry and science, not for medical purposes
Medical services; medical analysis relating to the treatment of persons; Gene and genome assay services, for treatment purposes; medical services and medical services, in relation to the fields of genome editing; genetic counseling; gene therapy services; Medical services, namely services for the preparation of medical reports; medical services, namely, providing personalised healthcare and medical information; medical services, namely, providing gene therapy recommendations; providing of medical information and medical counselling services in relation to the fields of medical services, health care services; medical therapy consultancy, in relation to the fields of genome editing; medical counselling relating to recombinases and integrases for the treatment of diseases
Scientific and technological services and research, especially creation of bioinformatic algorithms and models; science and technology services in the nature of gene therapies, scientific and technological research in the nature of gene editing technology, scientific development services, technological development, in the fields of gene, genome and cell editing, genome modulation, genome modification, engineering, gene regulation, repair and therapy and for the development of pharmaceutical and biological preparations or medications for humans and diagnostic goods and services; consultancy services relating to development of pharmaceutical and biological preparations or medications for humans in the field of gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy; genome engineering services; scientific research relating to genetics, and scientific research, in the field of genome editing; analytical scientific laboratory services; medical r...
General Information
| Serial Number | 79408326 |
| Word Mark | SEAMLESS |
| Filing Date | Thursday, December 14, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, May 21, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the wording "SEAMLESS" in stylized font in gradient from blue to green next to the letter "S" comprised of curved bands in green and blue. |
| Goods and Services | Pharmaceutical and biological preparations and, gene therapies and gene-editing therapies, all for the treatment of genetic and viral diseases; medical, pharmaceutical and biopharmaceutical preparations and programmable recombinases substances for the treatment of genetic and viral diseases; pharmaceutical goods and preparations, namely, gene transfer, regulation, modulation and delivery medications for the treatment of genetic and viral diseases and disorders; products, agents, for medical purposes, for veterinary purposes in the nature of gene and gene editing therapies; genome editable enzymes being enzymes for medical purposes; DNA recombinant enzymes being enzymes for medical purposes; DNA editable enzymes, especially, recombinases and integrases being enzymes for medical purposes; genome editable enzymes for the treatment of diseases being enzymes for medical purposes; DNA recombinant enzymes for the treatment of diseases being enzymes for medical purposes; DNA editable enzymes, in particular recombinases and integrases, for the treatment of diseases being enzymes for medical purposes |
| Goods and Services | Chemicals for use in industry and science; biological preparations for use in industry and science, biological reagents, for use in industry and science, not for medical purposes |
| Goods and Services | Medical services; medical analysis relating to the treatment of persons; Gene and genome assay services, for treatment purposes; medical services and medical services, in relation to the fields of genome editing; genetic counseling; gene therapy services; Medical services, namely services for the preparation of medical reports; medical services, namely, providing personalised healthcare and medical information; medical services, namely, providing gene therapy recommendations; providing of medical information and medical counselling services in relation to the fields of medical services, health care services; medical therapy consultancy, in relation to the fields of genome editing; medical counselling relating to recombinases and integrases for the treatment of diseases |
| Goods and Services | Scientific and technological services and research, especially creation of bioinformatic algorithms and models; science and technology services in the nature of gene therapies, scientific and technological research in the nature of gene editing technology, scientific development services, technological development, in the fields of gene, genome and cell editing, genome modulation, genome modification, engineering, gene regulation, repair and therapy and for the development of pharmaceutical and biological preparations or medications for humans and diagnostic goods and services; consultancy services relating to development of pharmaceutical and biological preparations or medications for humans in the field of gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy; genome engineering services; scientific research relating to genetics, and scientific research, in the field of genome editing; analytical scientific laboratory services; medical research laboratory services; scientific laboratory services; gene therapy research laboratories; scientific research and development; development of pharmaceutical preparations and medicines; pharmaceutical products development; bioinformatic research for identification of target sequences for genome editing in a cell's DNA; scientific research in the nature of bioinformatic research for identification of target sequences for genome editing in a cell's DNA by genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases; scientific research in the nature of bioinformatic or computational analysis to identify target sequences in a cell's DNA; screening processes, in silico DNA screening using bioinformatics and computational approaches and DNA high-throughput screening, for the identification of genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases, all for scientific research purposes; scientific research and development for the pharmaceutical industry; technological consultancy in the field of diseases by means of genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Seamless Therapeutics GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
Trademark Events
| Event Date | Event Description |
| Thursday, October 31, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, November 4, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 5, 2024 | ASSIGNED TO EXAMINER |
| Thursday, November 14, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, November 15, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, November 22, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, November 4, 2024 | APPLICATION FILING RECEIPT MAILED |
| Friday, November 22, 2024 | REFUSAL PROCESSED BY MPU |
| Wednesday, May 21, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 21, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 21, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, December 14, 2024 | REFUSAL PROCESSED BY IB |
